首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1866471

催產素市場：預測（2025-2030 年）

Oxytocin Market - Forecasts from 2025 to 2030

出版日期: 2025年11月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球催產素市場規模預計將從 2025 年的 1.2249 億美元成長到 2030 年的 1.57078 億美元，複合年成長率為 5.10%。

受分娩併發症日益增多以及全球範圍內醫院分娩率上升的推動，全球催產素市場正穩步成長。催產素是一種用於引產、增強子宮收縮和減少產後出血的激素，在應對這些併發症至關重要。北美憑藉其先進的醫療基礎設施和對孕產相關問題的高度重視，在市場上佔據主導地位；而亞太地區則因醫療服務可及性的提高而呈現快速成長。然而，一些國家對催產素使用的部分禁令，對市場擴張構成了重大挑戰。

市場促進因素

催產素市場的主要促進因素是分娩併發症發生率的上升，使得催產素在應對分娩和產後挑戰方面發揮著至關重要的作用。子癇、心肌病、栓塞、敗血症和呼吸窘迫症候群等疾病的發生率不斷增加，導致對催產素的需求也隨之成長，這些催產素可用於引產、輔助分娩和止血。醫療設施的改善推動了醫院分娩率的上升，這也進一步促進了市場成長。隨著越來越多的女性選擇醫院分娩，對用於應對分娩併發症的催產素的需求持續成長。這一趨勢在醫療基礎設施不斷完善、醫療服務可近性不斷提高的發展中地區尤為明顯。

介紹
北美洲
- 指示
- 按劑型
- 最終用戶
- 透過分銷管道
- 按國家/地區
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 指示
- 按劑型
- 最終用戶
- 透過分銷管道
- 按國家/地區
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 指示
- 按劑型
- 最終用戶
- 透過分銷管道
- 按國家/地區
  - 英國
  - 德國
  - 法國
  - 西班牙
  - 其他
中東和非洲
- 指示
- 按劑型
- 最終用戶
- 透過分銷管道
- 按國家/地區
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 指示
- 按劑型
- 最終用戶
- 透過分銷管道
- 按國家/地區
  - 中國
  - 日本
  - 印度
  - 韓國
  - 台灣
  - 其他

第10章競爭格局與分析

主要企業和策略分析
市佔率分析
併購、協議和合作
競爭對手儀錶板

第11章公司簡介

Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc
Grindeks
Taj Pharmaceuticals Ltd.
Karnataka Antibiotics & Pharmaceuticals Ltd.（KAPL）

第12章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要收益
調查方法
簡稱

簡介目錄

Product Code: KSI061614112

The Oxytocin Market is anticipated to grow from USD 122.490 million in 2025 to USD 157.078 million by 2030, registering a 5.10% CAGR.

The global oxytocin market is experiencing steady growth, driven by the rising prevalence of childbirth complications and increasing hospital-based births worldwide. Oxytocin, a hormone used to induce labor, strengthen uterine contractions, and control postpartum bleeding, is critical in addressing these complications. North America dominates the market due to its advanced healthcare infrastructure and high awareness of pregnancy-related issues, while the Asia-Pacific region is witnessing rapid growth due to improved access to medical facilities. However, partial bans on oxytocin in various countries pose a significant challenge to market expansion.

Market Drivers

The primary driver of the oxytocin market is the increasing incidence of childbirth complications, which necessitates the use of oxytocin to manage labor and postpartum challenges. Conditions such as eclampsia, cardiomyopathy, embolism, sepsis, and respiratory distress are becoming more prevalent, heightening the demand for oxytocin to induce or support labor and control bleeding. The growing trend of hospital births, facilitated by improved access to healthcare facilities, further boosts market growth. As more women opt for hospital deliveries, the need for oxytocin to address complications during childbirth continues to rise. This trend is particularly pronounced in developing regions, where healthcare infrastructure is expanding, enabling greater access to medical interventions.

Market Segmentation

The oxytocin market can be segmented by application (labor induction, postpartum hemorrhage control, and others), end-user (hospitals, clinics, and others), and geography (North America, South America, Europe, Middle East and Africa, Asia-Pacific). These segments reflect the diverse clinical applications and regional dynamics driving the market, with hospitals being the primary end-users due to the controlled administration of oxytocin in medical settings.

Geographical Outlook

North America holds a significant market share, attributed to its robust healthcare system, high awareness of childbirth complications, and widespread adoption of oxytocin in clinical settings. The region's advanced medical infrastructure ensures effective diagnosis and management of pregnancy-related issues, supporting market dominance. Conversely, the Asia-Pacific region is emerging as a high-growth market, driven by increasing access to medical facilities for pregnant women and rising healthcare investments. Countries in this region are witnessing a surge in hospital births, which directly correlates with higher oxytocin usage.

Challenges

The market faces a notable restraint in the form of partial bans on oxytocin in several countries, driven by concerns over misuse or overuse in non-medical settings. These regulatory restrictions could limit market growth by reducing availability in certain regions. Additionally, ensuring safe and controlled administration of oxytocin remains a challenge, particularly in areas with less developed healthcare systems.

Competitive Landscape

Key players in the oxytocin market are focusing on strategies such as product development, regulatory compliance, and partnerships to strengthen their market position. Companies are investing in research to enhance the safety and efficacy of oxytocin formulations, while also navigating regional regulations to ensure market access.

The oxytocin market is poised for steady growth, propelled by rising childbirth complications and increased hospital births. North America's dominance and Asia-Pacific's rapid growth highlight the market's regional dynamics. However, regulatory bans pose challenges that require strategic navigation by industry players. Continued focus on safe, effective oxytocin use and healthcare access will drive market expansion during the forecast period.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Indication

Antepartum Hemorrhage
Postpartum Hemorrhage (PPH)
Labor Induction
Uterine Atony
Miscarriage Management
Lactation Support

By Dosage Form

Injection
Nasal Spray
Other Forms

By End-User

Hospitals
Maternity Clinics
Home Birth Settings

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. OXYTOCIN MARKET BY INDICATION

5.1. Introduction
5.2. Antepartum Hemorrhage
5.3. Postpartum Hemorrhage (PPH)
5.4. Labor Induction
5.5. Uterine Atony
5.6. Miscarriage Management
5.7. Lactation Support

6. OXYTOCIN MARKET BY DOSAGE FORM

6.1. Introduction
6.2. Injection
6.3. Nasal Spray
6.4. Other Forms

7. OXYTOCIN MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Maternity Clinics
7.4. Home Birth Settings

8. OXYTOCIN MARKET BY DISTRIBUTION CHANNEL

8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online Pharmacies
8.5. Others

9. OXYTOCIN MARKET BY GEOGRAPHY

9.1. Introduction
9.2. North America
- 9.2.1. By Indication
- 9.2.2. By Dosage Form
- 9.2.3. By End-User
- 9.2.4. By Distribution Channel
- 9.2.5. By Country
  - 9.2.5.1. USA
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. South America
- 9.3.1. By Indication
- 9.3.2. By Dosage Form
- 9.3.3. By End-User
- 9.3.4. By Distribution Channel
- 9.3.5. By Country
  - 9.3.5.1. Brazil
  - 9.3.5.2. Argentina
  - 9.3.5.3. Others
9.4. Europe
- 9.4.1. By Indication
- 9.4.2. By Dosage Form
- 9.4.3. By End-User
- 9.4.4. By Distribution Channel
- 9.4.5. By Country
  - 9.4.5.1. United Kingdom
  - 9.4.5.2. Germany
  - 9.4.5.3. France
  - 9.4.5.4. Spain
  - 9.4.5.5. Others
9.5. Middle East and Africa
- 9.5.1. By Indication
- 9.5.2. By Dosage Form
- 9.5.3. By End-User
- 9.5.4. By Distribution Channel
- 9.5.5. By Country
  - 9.5.5.1. Saudi Arabia
  - 9.5.5.2. UAE
  - 9.5.5.3. Others
9.6. Asia Pacific
- 9.6.1. By Indication
- 9.6.2. By Dosage Form
- 9.6.3. By End-User
- 9.6.4. By Distribution Channel
- 9.6.5. By Country
  - 9.6.5.1. China
  - 9.6.5.2. Japan
  - 9.6.5.3. India
  - 9.6.5.4. South Korea
  - 9.6.5.5. Taiwan
  - 9.6.5.6. Others